Wednesday, July 12, 2017 11:00:57 AM
ALIM (T/$3-5)Alimera Sciences... The Company focuses on diseases affecting the back of the eye or retina. The Company's product is ILUVIEN, which is developed to treat diabetic macular edema (DME). DME is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness.
July 12,2017...today announced that patients are now being treated in Italy with ILUVIEN, its sustained release intravitreal implant that is indicated in Europe for the treatment of vision impairment associated with chronic diabetic macular edema (DME).
ILUVIEN is designated a Class H product in Italy and, as such, is hospital-administered and fully reimbursed for those patients who have previously undergone cataract surgery.
“Italy is an important market for ILUVIEN as it has Europe's fourth largest diabetes population1 and a medical community that regularly uses corticosteroids to treat eye diseases
Daily chart...this is a "Breakout" type move with NEWS...but it doesn't mean you should sell the farm and buy this "penny stock"...maybe buy the first drawback...maybe like in the last post about silver; you ask the 60 minute chart for help in defining an entry PRICE...
60minute...maybe buy the first drawback on the 60 minute chart "CCI cycle"...?...in any case you don't go all in... maybe 1/2 position around $1.50 if your emotions/ego forces you to (LOL)...and then let the 60 minute help with the other half...listen to the Chart and indicators...don't listen to me or some stranger with an opinion...SOoooooooooWhat if there is a $3 or $5 price target stated by some hole-in-the-wall brokerage outfit...learn how to enter a stock...learn what those technicals are saying to you...
60 minute...lets see if 60 minute CCI can get oversold...
ALIM
July 12,2017...today announced that patients are now being treated in Italy with ILUVIEN, its sustained release intravitreal implant that is indicated in Europe for the treatment of vision impairment associated with chronic diabetic macular edema (DME).
ILUVIEN is designated a Class H product in Italy and, as such, is hospital-administered and fully reimbursed for those patients who have previously undergone cataract surgery.
“Italy is an important market for ILUVIEN as it has Europe's fourth largest diabetes population1 and a medical community that regularly uses corticosteroids to treat eye diseases
Daily chart...this is a "Breakout" type move with NEWS...but it doesn't mean you should sell the farm and buy this "penny stock"...maybe buy the first drawback...maybe like in the last post about silver; you ask the 60 minute chart for help in defining an entry PRICE...
60minute...maybe buy the first drawback on the 60 minute chart "CCI cycle"...?...in any case you don't go all in... maybe 1/2 position around $1.50 if your emotions/ego forces you to (LOL)...and then let the 60 minute help with the other half...listen to the Chart and indicators...don't listen to me or some stranger with an opinion...SOoooooooooWhat if there is a $3 or $5 price target stated by some hole-in-the-wall brokerage outfit...learn how to enter a stock...learn what those technicals are saying to you...
60 minute...lets see if 60 minute CCI can get oversold...
ALIM
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
